✦ LIBER ✦

Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma

✍ Scribed by Joseph A Sparano; Peter H Wiernik; Xiaoping Hu; Catherine Sarta; David H Henry; Howard Ratech

Publisher: Springer US
Year: 1998
Tongue: English
Weight: 690 KB
Volume: 15
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02787345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma kinetics of a cholesterol-rich mi

Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s and non-Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDE

✍ Ketlin V. Pinheiro; Vania T. M. Hungria; Elisabeth S. Ficker; Claudete J. Valdug 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 282 KB

A randomized comparison of the efficacy

A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-hodgkin's lymphoma

✍ Reena Nair; Gopal Ramakrishnan; Narendran N. Nair; Tapan K. Saikia; Purvish M. P 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

## BACKGROUND. Combination chemotherapy consisting of methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisolone, and bleomycin (MACOP-B) has been frequently used for the treatment of non-Hodgkin's lymphoma. This randomized study was undertaken to assess the efficacy and toxicity of th

Four versus six courses of a dose-escala

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation : Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma

✍ Nobert Schmitz; Marita Kloess; Marcel Reiser; Wolfgang E. Berdel; Bernd Metzner; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB